RAPP (STOCKS)
Rapport Therapeutics, Inc. Common Stock
$29.570000
+1.240000 (+4.38%)
Prev close: $28.330000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Abraham N. Ceesay
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,415.84M
- Employees
- 69
- P/E (TTM)
- -9.72
- P/B (TTM)
- 3.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.19 | $-0.97 | -0.2167 | -22.26% |
|
Mar 2026 (Q1)
|
$-0.42 | $-0.68 | +0.2642 | +38.61% |
|
Dec 2025 (Q4)
|
$-0.72 | $-0.69 | -0.0284 | -4.11% |
|
Sep 2025 (Q3)
|
$-0.71 | $-0.79 | +0.0809 | +10.23% |